Get In Touch With Us
Inhibikase Therapeutics is a pharmaceutical company headquartered in Delaware with additional offices in Boston.
A clinical-stage pharmaceutical company developing protein kinase inhibitor therapeutics to modify the course of pulmonary arterial hypertension (PAH).
For more information regarding our company, partnerships, or drug candidates, please reach out to us using the information provided.
Delaware Office
1000 N. West Street
Suite 1200
Wilmington, DE 19801
Massachusetts Office
101 Federal Street
Suite 1900
Boston, MA 02110